The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pregabalin API Market Research Report 2024
Synopsis
Market Analysis and Insights: Global Pregabalin API Market
Due to the COVID-19 pandemic, the global Pregabalin API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Pregabalin API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Tablet segment is altered to an % CAGR throughout this forecast period.
North America Pregabalin API market is estimated at US$ million in 2021, while Europe is forecast to reach US$ million by 2028. The proportion of the North America is % in 2021, while Europe percentage is %, and it is predicted that Europe share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global major manufacturers of Pregabalin API include SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila and Sunshine Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Pregabalin API in 2021.
Global Pregabalin API Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Pregabalin API Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Tablet
Capsule
Oral Liquid
By Company
SUANFARMA
VASUDHA PHARMA
Atom Pharma
Sienna Biotec
Kopran
Teva
Afton Pharma
Cadila
Sunshine Pharmaceutical
Hanmi Fine Chemical
Rivocean Jiangsu Pharmaceutical
Hubei Vanz Pharm
Menovo
Saintsun
SyncoZymes
Taian Aidi Biotechnology
Production by Region
North America
Europe
China
India
South Korea
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Market Analysis and Insights: Global Pregabalin API Market
Due to the COVID-19 pandemic, the global Pregabalin API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Pregabalin API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Tablet segment is altered to an % CAGR throughout this forecast period.
North America Pregabalin API market is estimated at US$ million in 2021, while Europe is forecast to reach US$ million by 2028. The proportion of the North America is % in 2021, while Europe percentage is %, and it is predicted that Europe share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global major manufacturers of Pregabalin API include SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila and Sunshine Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Pregabalin API in 2021.
Global Pregabalin API Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Pregabalin API Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Tablet
Capsule
Oral Liquid
By Company
SUANFARMA
VASUDHA PHARMA
Atom Pharma
Sienna Biotec
Kopran
Teva
Afton Pharma
Cadila
Sunshine Pharmaceutical
Hanmi Fine Chemical
Rivocean Jiangsu Pharmaceutical
Hubei Vanz Pharm
Menovo
Saintsun
SyncoZymes
Taian Aidi Biotechnology
Production by Region
North America
Europe
China
India
South Korea
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Index1 Pregabalin API Market Overview
1.1 Product Overview and Scope of Pregabalin API
1.2 Pregabalin API Segment by Type
1.2.1 Global Pregabalin API Market Size Growth Rate Analysis by Type 2022 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Pregabalin API Segment by Application
1.3.1 Global Pregabalin API Consumption Comparison by Application: 2022 VS 2028
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Oral Liquid
1.4 Global Market Growth Prospects
1.4.1 Global Pregabalin API Revenue Estimates and Forecasts (2017-2028)
1.4.2 Global Pregabalin API Production Capacity Estimates and Forecasts (2017-2028)
1.4.3 Global Pregabalin API Production Estimates and Forecasts (2017-2028)
1.5 Global Market Size by Region
1.5.1 Global Pregabalin API Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
1.5.2 North America Pregabalin API Estimates and Forecasts (2017-2028)
1.5.3 Europe Pregabalin API Estimates and Forecasts (2017-2028)
1.5.4 China Pregabalin API Estimates and Forecasts (2017-2028)
1.5.5 India Pregabalin API Estimates and Forecasts (2017-2028)
1.5.6 South Korea Pregabalin API Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
2.1 Global Pregabalin API Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Pregabalin API Revenue Market Share by Manufacturers (2017-2022)
2.3 Pregabalin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Pregabalin API Average Price by Manufacturers (2017-2022)
2.5 Manufacturers Pregabalin API Production Sites, Area Served, Product Types
2.6 Pregabalin API Market Competitive Situation and Trends
2.6.1 Pregabalin API Market Concentration Rate
2.6.2 Global 5 and 10 Largest Pregabalin API Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Pregabalin API Market Share by Region (2017-2022)
3.2 Global Pregabalin API Revenue Market Share by Region (2017-2022)
3.3 Global Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 North America Pregabalin API Production
3.4.1 North America Pregabalin API Production Growth Rate (2017-2022)
3.4.2 North America Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Pregabalin API Production
3.5.1 Europe Pregabalin API Production Growth Rate (2017-2022)
3.5.2 Europe Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 China Pregabalin API Production
3.6.1 China Pregabalin API Production Growth Rate (2017-2022)
3.6.2 China Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 India Pregabalin API Production
3.7.1 India Pregabalin API Production Growth Rate (2017-2022)
3.7.2 India Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.8 South Korea Pregabalin API Production
3.8.1 South Korea Pregabalin API Production Growth Rate (2017-2022)
3.8.2 South Korea Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Pregabalin API Consumption by Region
4.1 Global Pregabalin API Consumption by Region
4.1.1 Global Pregabalin API Consumption by Region
4.1.2 Global Pregabalin API Consumption Market Share by Region
4.2 North America
4.2.1 North America Pregabalin API Consumption by Country
4.2.2 United States
4.2.3 Canada
4.3 Europe
4.3.1 Europe Pregabalin API Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Pregabalin API Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Pregabalin API Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Segment by Type
5.1 Global Pregabalin API Production Market Share by Type (2017-2022)
5.2 Global Pregabalin API Revenue Market Share by Type (2017-2022)
5.3 Global Pregabalin API Price by Type (2017-2022)
6 Segment by Application
6.1 Global Pregabalin API Production Market Share by Application (2017-2022)
6.2 Global Pregabalin API Revenue Market Share by Application (2017-2022)
6.3 Global Pregabalin API Price by Application (2017-2022)
7 Key Companies Profiled
7.1 SUANFARMA
7.1.1 SUANFARMA Pregabalin API Corporation Information
7.1.2 SUANFARMA Pregabalin API Product Portfolio
7.1.3 SUANFARMA Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.1.4 SUANFARMA Main Business and Markets Served
7.1.5 SUANFARMA Recent Developments/Updates
7.2 VASUDHA PHARMA
7.2.1 VASUDHA PHARMA Pregabalin API Corporation Information
7.2.2 VASUDHA PHARMA Pregabalin API Product Portfolio
7.2.3 VASUDHA PHARMA Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.2.4 VASUDHA PHARMA Main Business and Markets Served
7.2.5 VASUDHA PHARMA Recent Developments/Updates
7.3 Atom Pharma
7.3.1 Atom Pharma Pregabalin API Corporation Information
7.3.2 Atom Pharma Pregabalin API Product Portfolio
7.3.3 Atom Pharma Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.3.4 Atom Pharma Main Business and Markets Served
7.3.5 Atom Pharma Recent Developments/Updates
7.4 Sienna Biotec
7.4.1 Sienna Biotec Pregabalin API Corporation Information
7.4.2 Sienna Biotec Pregabalin API Product Portfolio
7.4.3 Sienna Biotec Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.4.4 Sienna Biotec Main Business and Markets Served
7.4.5 Sienna Biotec Recent Developments/Updates
7.5 Kopran
7.5.1 Kopran Pregabalin API Corporation Information
7.5.2 Kopran Pregabalin API Product Portfolio
7.5.3 Kopran Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.5.4 Kopran Main Business and Markets Served
7.5.5 Kopran Recent Developments/Updates
7.6 Teva
7.6.1 Teva Pregabalin API Corporation Information
7.6.2 Teva Pregabalin API Product Portfolio
7.6.3 Teva Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.6.4 Teva Main Business and Markets Served
7.6.5 Teva Recent Developments/Updates
7.7 Afton Pharma
7.7.1 Afton Pharma Pregabalin API Corporation Information
7.7.2 Afton Pharma Pregabalin API Product Portfolio
7.7.3 Afton Pharma Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.7.4 Afton Pharma Main Business and Markets Served
7.7.5 Afton Pharma Recent Developments/Updates
7.8 Cadila
7.8.1 Cadila Pregabalin API Corporation Information
7.8.2 Cadila Pregabalin API Product Portfolio
7.8.3 Cadila Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.8.4 Cadila Main Business and Markets Served
7.7.5 Cadila Recent Developments/Updates
7.9 Sunshine Pharmaceutical
7.9.1 Sunshine Pharmaceutical Pregabalin API Corporation Information
7.9.2 Sunshine Pharmaceutical Pregabalin API Product Portfolio
7.9.3 Sunshine Pharmaceutical Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.9.4 Sunshine Pharmaceutical Main Business and Markets Served
7.9.5 Sunshine Pharmaceutical Recent Developments/Updates
7.10 Hanmi Fine Chemical
7.10.1 Hanmi Fine Chemical Pregabalin API Corporation Information
7.10.2 Hanmi Fine Chemical Pregabalin API Product Portfolio
7.10.3 Hanmi Fine Chemical Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.10.4 Hanmi Fine Chemical Main Business and Markets Served
7.10.5 Hanmi Fine Chemical Recent Developments/Updates
7.11 Rivocean Jiangsu Pharmaceutical
7.11.1 Rivocean Jiangsu Pharmaceutical Pregabalin API Corporation Information
7.11.2 Rivocean Jiangsu Pharmaceutical Pregabalin API Product Portfolio
7.11.3 Rivocean Jiangsu Pharmaceutical Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.11.4 Rivocean Jiangsu Pharmaceutical Main Business and Markets Served
7.11.5 Rivocean Jiangsu Pharmaceutical Recent Developments/Updates
7.12 Hubei Vanz Pharm
7.12.1 Hubei Vanz Pharm Pregabalin API Corporation Information
7.12.2 Hubei Vanz Pharm Pregabalin API Product Portfolio
7.12.3 Hubei Vanz Pharm Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.12.4 Hubei Vanz Pharm Main Business and Markets Served
7.12.5 Hubei Vanz Pharm Recent Developments/Updates
7.13 Menovo
7.13.1 Menovo Pregabalin API Corporation Information
7.13.2 Menovo Pregabalin API Product Portfolio
7.13.3 Menovo Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.13.4 Menovo Main Business and Markets Served
7.13.5 Menovo Recent Developments/Updates
7.14 Saintsun
7.14.1 Saintsun Pregabalin API Corporation Information
7.14.2 Saintsun Pregabalin API Product Portfolio
7.14.3 Saintsun Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.14.4 Saintsun Main Business and Markets Served
7.14.5 Saintsun Recent Developments/Updates
7.15 SyncoZymes
7.15.1 SyncoZymes Pregabalin API Corporation Information
7.15.2 SyncoZymes Pregabalin API Product Portfolio
7.15.3 SyncoZymes Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.15.4 SyncoZymes Main Business and Markets Served
7.15.5 SyncoZymes Recent Developments/Updates
7.16 Taian Aidi Biotechnology
7.16.1 Taian Aidi Biotechnology Pregabalin API Corporation Information
7.16.2 Taian Aidi Biotechnology Pregabalin API Product Portfolio
7.16.3 Taian Aidi Biotechnology Pregabalin API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.16.4 Taian Aidi Biotechnology Main Business and Markets Served
7.16.5 Taian Aidi Biotechnology Recent Developments/Updates
8 Pregabalin API Manufacturing Cost Analysis
8.1 Pregabalin API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pregabalin API
8.4 Pregabalin API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pregabalin API Distributors List
9.3 Pregabalin API Customers
10 Market Dynamics
10.1 Pregabalin API Industry Trends
10.2 Pregabalin API Market Drivers
10.3 Pregabalin API Market Challenges
10.4 Pregabalin API Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Pregabalin API by Region (2023-2028)
11.2 North America Pregabalin API Production, Revenue Forecast (2023-2028)
11.3 Europe Pregabalin API Production, Revenue Forecast (2023-2028)
11.4 China Pregabalin API Production, Revenue Forecast (2023-2028)
11.5 India Pregabalin API Production, Revenue Forecast (2023-2028)
11.6 South Korea Pregabalin API Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Pregabalin API
12.2 North America Forecasted Consumption of Pregabalin API by Country
12.3 Europe Market Forecasted Consumption of Pregabalin API by Country
12.4 Asia Pacific Market Forecasted Consumption of Pregabalin API by Region
12.5 Latin America Forecasted Consumption of Pregabalin API by Country
13 Forecast by Type and by Application (2023-2028)
13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
13.1.1 Global Forecasted Production of Pregabalin API by Type (2023-2028)
13.1.2 Global Forecasted Revenue of Pregabalin API by Type (2023-2028)
13.1.3 Global Forecasted Price of Pregabalin API by Type (2023-2028)
13.2 Global Forecasted Consumption of Pregabalin API by Application (2023-2028)
13.2.1 Global Forecasted Production of Pregabalin API by Application (2023-2028)
13.2.2 Global Forecasted Revenue of Pregabalin API by Application (2023-2028)
13.2.3 Global Forecasted Price of Pregabalin API by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pregabalin API Market Size by Type (Tons) & (US$ Million) (2022 VS 2028)
Table 2. Global Pregabalin API Market Size by Application (Tons) & (US$ Million) (2022 VS 2028)
Table 3. Pregabalin API Market Size Comparison by Region: 2017 VS 2021 VS 2028
Table 4. Global Pregabalin API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 5. Global Pregabalin API Production (Tons) by Manufacturers (2017-2022)
Table 6. Global Pregabalin API Production Market Share by Manufacturers (2017-2022)
Table 7. Global Pregabalin API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 8. Global Pregabalin API Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pregabalin API as of 2021)
Table 10. Global Market Pregabalin API Average Price (US$/Ton) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Pregabalin API Production Sites and Area Served
Table 12. Manufacturers Pregabalin API Product Types
Table 13. Global Pregabalin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Pregabalin API Production Capacity (Tons) by Region (2017-2022)
Table 16. Global Pregabalin API Production (Tons) by Region (2017-2022)
Table 17. Global Pregabalin API Revenue (US$ Million) by Region (2017-2022)
Table 18. Global Pregabalin API Revenue Market Share by Region (2017-2022)
Table 19. Global Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 20. North America Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 21. Europe Pregabalin API Production (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 22. China Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 23. India Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 24. South Korea Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 25. Global Pregabalin API Consumption Market by Region (2017-2022) & (Tons)
Table 26. Global Pregabalin API Consumption Market Share by Region (2017-2022)
Table 27. North America Pregabalin API Consumption by Country (2017-2022) & (Tons)
Table 28. Europe Pregabalin API Consumption by Country (2017-2022) & (Tons)
Table 29. Asia Pacific Pregabalin API Consumption by Region (2017-2022) & (Tons)
Table 30. Latin America Pregabalin API Consumption by Country (2017-2022) & (Tons)
Table 31. Global Pregabalin API Production (Tons) by Type (2017-2022)
Table 32. Global Pregabalin API Production Market Share by Type (2017-2022)
Table 33. Global Pregabalin API Revenue (US$ Million) by Type (2017-2022)
Table 34. Global Pregabalin API Revenue Share by Type (2017-2022)
Table 35. Global Pregabalin API Price (US$/Ton) by Type (2017-2022)
Table 36. Global Pregabalin API Production by Application (2017-2022) & (Tons)
Table 37. Global Pregabalin API Production Market Share by Application (2017-2022)
Table 38. Global Pregabalin API Revenue (US$ Million) by Application (2017-2022)
Table 39. Global Pregabalin API Revenue Share by Application (2017-2022)
Table 40. Global Pregabalin API Price (US$/Ton) by Application (2017-2022)
Table 41. SUANFARMA Pregabalin API Corporation Information
Table 42. SUANFARMA Specification and Application
Table 43. SUANFARMA Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 44. SUANFARMA Main Business and Markets Served
Table 45. SUANFARMA Recent Developments/Updates
Table 46. VASUDHA PHARMA Pregabalin API Corporation Information
Table 47. VASUDHA PHARMA Specification and Application
Table 48. VASUDHA PHARMA Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 49. VASUDHA PHARMA Main Business and Markets Served
Table 50. VASUDHA PHARMA Recent Developments/Updates
Table 51. Atom Pharma Pregabalin API Corporation Information
Table 52. Atom Pharma Specification and Application
Table 53. Atom Pharma Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 54. Atom Pharma Main Business and Markets Served
Table 55. Atom Pharma Recent Developments/Updates
Table 56. Sienna Biotec Pregabalin API Corporation Information
Table 57. Sienna Biotec Specification and Application
Table 58. Sienna Biotec Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 59. Sienna Biotec Main Business and Markets Served
Table 60. Sienna Biotec Recent Developments/Updates
Table 61. Kopran Pregabalin API Corporation Information
Table 62. Kopran Specification and Application
Table 63. Kopran Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 64. Kopran Main Business and Markets Served
Table 65. Kopran Recent Developments/Updates
Table 66. Teva Pregabalin API Corporation Information
Table 67. Teva Specification and Application
Table 68. Teva Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 69. Teva Main Business and Markets Served
Table 70. Teva Recent Developments/Updates
Table 71. Afton Pharma Pregabalin API Corporation Information
Table 72. Afton Pharma Specification and Application
Table 73. Afton Pharma Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 74. Afton Pharma Main Business and Markets Served
Table 75. Afton Pharma Recent Developments/Updates
Table 76. Cadila Pregabalin API Corporation Information
Table 77. Cadila Specification and Application
Table 78. Cadila Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 79. Cadila Main Business and Markets Served
Table 80. Cadila Recent Developments/Updates
Table 81. Sunshine Pharmaceutical Pregabalin API Corporation Information
Table 82. Sunshine Pharmaceutical Specification and Application
Table 83. Sunshine Pharmaceutical Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 84. Sunshine Pharmaceutical Main Business and Markets Served
Table 85. Sunshine Pharmaceutical Recent Developments/Updates
Table 86. Hanmi Fine Chemical Pregabalin API Corporation Information
Table 87. Hanmi Fine Chemical Specification and Application
Table 88. Hanmi Fine Chemical Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 89. Hanmi Fine Chemical Main Business and Markets Served
Table 90. Hanmi Fine Chemical Recent Developments/Updates
Table 91. Rivocean Jiangsu Pharmaceutical Pregabalin API Corporation Information
Table 92. Rivocean Jiangsu Pharmaceutical Specification and Application
Table 93. Rivocean Jiangsu Pharmaceutical Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 94. Rivocean Jiangsu Pharmaceutical Main Business and Markets Served
Table 95. Rivocean Jiangsu Pharmaceutical Recent Developments/Updates
Table 96. Hubei Vanz Pharm Pregabalin API Corporation Information
Table 97. Hubei Vanz Pharm Specification and Application
Table 98. Hubei Vanz Pharm Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 99. Hubei Vanz Pharm Main Business and Markets Served
Table 100. Hubei Vanz Pharm Recent Developments/Updates
Table 101. Menovo Pregabalin API Corporation Information
Table 102. Menovo Specification and Application
Table 103. Menovo Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 104. Menovo Main Business and Markets Served
Table 105. Menovo Recent Developments/Updates
Table 106. Saintsun Pregabalin API Corporation Information
Table 107. Saintsun Specification and Application
Table 108. Saintsun Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 109. Saintsun Main Business and Markets Served
Table 110. Saintsun Recent Developments/Updates
Table 111. Saintsun Pregabalin API Corporation Information
Table 112. SyncoZymes Specification and Application
Table 113. SyncoZymes Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 114. SyncoZymes Main Business and Markets Served
Table 115. SyncoZymes Recent Developments/Updates
Table 116. Taian Aidi Biotechnology Pregabalin API Corporation Information
Table 117. Taian Aidi Biotechnology Pregabalin API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 118. Taian Aidi Biotechnology Main Business and Markets Served
Table 119. Taian Aidi Biotechnology Recent Developments/Updates
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Pregabalin API Distributors List
Table 123. Pregabalin API Customers List
Table 124. Pregabalin API Market Trends
Table 125. Pregabalin API Market Drivers
Table 126. Pregabalin API Market Challenges
Table 127. Pregabalin API Market Restraints
Table 128. Global Pregabalin API Production (Tons) Forecast by Region (2023-2028)
Table 129. North America Pregabalin API Consumption Forecast by Country (2023-2028) & (Tons)
Table 130. Europe Pregabalin API Consumption Forecast by Country (2023-2028) & (Tons)
Table 131. Asia Pacific Pregabalin API Consumption Forecast by Region (2023-2028) & (Tons)
Table 132. Latin America Pregabalin API Consumption Forecast by Country (2023-2028) & (Tons)
Table 133. Global Pregabalin API Production Forecast by Type (2023-2028) & (Tons)
Table 134. Global Pregabalin API Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Pregabalin API Price Forecast by Type (2023-2028) & (US$/Ton)
Table 136. Global Pregabalin API Production Forecast by Application (2023-2028) & (Tons)
Table 137. Global Pregabalin API Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 138. Global Pregabalin API Price Forecast by Application (2023-2028) & (US$/Ton)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pregabalin API
Figure 2. Global Pregabalin API Market Share by Type: 2022 VS 2028
Figure 3. Purity ≥99% Product Picture
Figure 4. Purity ≥99.5% Product Picture
Figure 5. Global Pregabalin API Market Share by Application: 2022 VS 2028
Figure 6. Tablet
Figure 7. Capsule
Figure 8. Oral Liquid
Figure 9. Global Pregabalin API Revenue (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Pregabalin API Revenue (US$ Million) (2017-2028)
Figure 11. Global Pregabalin API Production Capacity (Tons) & (2017-2028)
Figure 12. Global Pregabalin API Production (Tons) & (2017-2028)
Figure 13. North America Pregabalin API Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 14. Europe Pregabalin API Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 15. China Pregabalin API Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 16. India Pregabalin API Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 17. South Korea Pregabalin API Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 18. Pregabalin API Production Share by Manufacturers in 2021
Figure 19. Global Pregabalin API Revenue Share by Manufacturers in 2021
Figure 20. Pregabalin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Market Pregabalin API Average Price (US$/Ton) of Key Manufacturers in 2021
Figure 22. The Global 5 and 10 Largest Players: Market Share by Pregabalin API Revenue in 2021
Figure 23. Global Pregabalin API Production Market Share by Region (2017-2022)
Figure 24. North America Pregabalin API Production (Tons) Growth Rate (2017-2022)
Figure 25. Europe Pregabalin API Production (Tons) Growth Rate (2017-2022)
Figure 26. China Pregabalin API Production (Tons) Growth Rate (2017-2022)
Figure 27. India Pregabalin API Production (Tons) Growth Rate (2017-2022)
Figure 28. South Korea Pregabalin API Production (Tons) Growth Rate (2017-2022)
Figure 29. Global Pregabalin API Consumption Market Share by Region (2017-2022)
Figure 30. North America Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 31. North America Pregabalin API Consumption Market Share by Country in 2021
Figure 32. Canada Pregabalin API Consumption Growth Rate (2017-2022) & (Tons)
Figure 33. U.S. Pregabalin API Consumption Growth Rate (2017-2022) & (Tons)
Figure 34. Europe Pregabalin API Consumption Growth Rate (2017-2022) & (Tons)
Figure 35. Europe Pregabalin API Consumption Market Share by Country in 2021
Figure 36. Germany Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 37. France Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 38. U.K. Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 39. Italy Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 40. Russia Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 41. Asia Pacific Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 42. Asia Pacific Pregabalin API Consumption Market Share by Regions in 2021
Figure 43. China Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 44. Japan Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 45. South Korea Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 46. China Taiwan Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 47. Southeast Asia Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 48. India Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 49. Australia Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 50. Latin America Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 51. Latin America Pregabalin API Consumption Market Share by Country in 2021
Figure 52. Mexico Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 53. Brazil Pregabalin API Consumption and Growth Rate (2017-2022) & (Tons)
Figure 54. Production Market Share of Pregabalin API by Type (2017-2022)
Figure 55. Production Market Share of Pregabalin API by Type in 2021
Figure 56. Revenue Share of Pregabalin API by Type (2017-2022)
Figure 57. Revenue Market Share of Pregabalin API by Type in 2021
Figure 58. Production Market Share of Pregabalin API by Application (2017-2022)
Figure 59. Production Market Share of Pregabalin API by Application in 2021
Figure 60. Revenue Share of Pregabalin API by Application (2017-2022)
Figure 61. Revenue Market Share of Pregabalin API by Application in 2021
Figure 62. Manufacturing Cost Structure of Pregabalin API
Figure 63. Manufacturing Process Analysis of Pregabalin API
Figure 64. Pregabalin API Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Global Pregabalin API Production Market Share Forecast by Region (2023-2028)
Figure 68. North America Pregabalin API Production (Tons) Growth Rate Forecast (2023-2028)
Figure 69. Europe Pregabalin API Production (Tons) Growth Rate Forecast (2023-2028)
Figure 70. China Pregabalin API Production (Tons) Growth Rate Forecast (2023-2028)
Figure 71. India Pregabalin API Production (Tons) Growth Rate Forecast (2023-2028)
Figure 72. South Korea Pregabalin API Production (Tons) Growth Rate Forecast (2023-2028)
Figure 73. Global Forecasted Demand Analysis of Pregabalin API (2017-2028) & (Tons)
Figure 74. Global Pregabalin API Production Market Share Forecast by Type (2023-2028)
Figure 75. Global Pregabalin API Revenue Market Share Forecast by Type (2023-2028)
Figure 76. Global Pregabalin API Production Market Share Forecast by Application (2023-2028)
Figure 77. Global Pregabalin API Revenue Market Share Forecast by Application (2023-2028)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
